ANGO · Angiodynamic Inc
United States · RS rating 30 · As of 2026-10-14
| Price | 11.05 USD |
|---|---|
| 1-day change | +1.4% |
| RS rating (overall / 1M / 3M / 12M) | 30 / 6 / 17 / 44 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 25 / 20 / 12 |
| Industry group (rank) | Medical-Products (98) |
| EPS growth Q/Q | -26.7% |
| Sales growth Q/Q | -1.3% |
| Distance from 52-week high | +31.5% |
| Market cap (USD) | $462.8M |